Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse

Key Points

• To analyze hypertrophic cardiomyopathy, myocarditis, and other myopericardial diseases alongside mitral valve prolapse.
• Comprehensive literature review of current diagnostic guidelines and management protocols.
• Assessment of clinical outcomes related to each condition and intervention strategies.
• Expert consensus from task force members on best practices.
• Identified key diagnostic criteria for hypertrophic cardiomyopathy and myocarditis with consensus endorsement.
• Established management recommendations for mitral valve prolapse leading to improved patient outcomes.
• Outlined the importance of interdisciplinary approaches in managing myopericardial diseases.